Related Experiment Videos
Long-term prazosin therapy for COPD pulmonary hypertension
J Lewczuk1, B Sobkowicz-Woźniak, P Piszko
1Department of Cardiology and Medicine, County Hospital, Wrocław, Poland.
Chest
|August 1, 1992
Abstract:
A 51-year-old patient with COPD, obesity, and pulmonary hypertension underwent long-term prazosin therapy after a successful hemodynamic response to 1 mg of oral prazosin. The 18-month administration of prazosin, in a dose of 3 mg a day, resulted in continued hemodynamic and echocardiographic benefits.